risks of glp-1 drugs Medications: Everything You Need to Know GLP-1: Genetic Variants Related to

Description

Exenatide reduces urinary transforming growth factor-beta1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria

Maja Mirkovic, MPH, RDN, CDN, CDCES, BC-ADM from In Control Nutrition reports that the most common side effect people with diabetes can develop is nausea, which affects between 15-45% of patients

Medical necessity The medication must be medically necessary for the treatment to be eligible for the Novo Nordisk PAP

Novo Nordisks share price rose by more than 4% on Monday on news of the launch, but is still down by 44% over the past year amid fierce competition from US rival Eli Lillys jabs Mounjaro and Zepbound